COVID-19 has had a deep impact on how we conduct clinical trials here in Ontario and around the world. Our community has faced extraordinary challenges requiring new ways of thinking and working together to advance science safely and deliver care. Now, as we are coming out on the other side of this pandemic, we are entering into a new era of clinical trials in Ontario. We are using technology to innovate processes and connect more effectively, prioritizing patients and the participant experience and advancing decentralized approaches to clinical trials. As we enter this new era of clinical trials in Ontario, we are motivated by our community’s spirit of innovation and collaboration, embracing new opportunities in the face of hardship, and advancing health research forward, faster, for an even brighter future in this province.
CTO’s Annual Report highlights the Ontario clinical trial community’s collective success and CTO’s newest initiatives.